1h Free Analyst Time
Spinal implant technology is at an inflection point as the convergence of advanced material science and clinical demand drives innovation. Growing incidences of degenerative disc disease, trauma and spinal deformities among aging and active populations have underscored the need for implants that not only restore structural integrity but also promote biological integration. In response, biomaterials have evolved from inert supports into multifunctional constructs capable of facilitating osseointegration, delivering therapeutics and adapting to physiological loading conditions. Researchers and device manufacturers are leveraging bioceramics, natural polymers and high-performance synthetics to optimize the balance between mechanical strength and biocompatibility. These materials are now tailored to specific anatomical requirements, surgical techniques and patient profiles, ensuring that implants are no longer one-size-fits-all but bespoke solutions for complex spinal pathologies. As a result, clinicians benefit from reduced complication rates and faster recovery, while patients experience improved quality of life. This introduction establishes the critical role biomaterials play in next-generation spinal implants and sets the stage for examining the transformative shifts, regulatory impacts, market segmentation, regional dynamics and strategic imperatives that define the current landscape.Speak directly to the analyst to clarify any post sales queries you may have.
Transformative Shifts Reshaping Spinal Implant Development
Over the past decade, the spinal implant market has undergone transformative shifts driven by breakthroughs in additive manufacturing, nanotechnology and bioactive coatings. Surgeons are increasingly adopting three-dimensional printing to fabricate patient-specific cages and rods, enabling precise anatomical matching and reducing intraoperative adjustments. Concurrently, nano-coatings on implant surfaces enhance cellular adhesion and modulate inflammatory responses, accelerating fusion and minimizing loosening. Rapid advances in bioabsorbable materials have introduced implants that degrade in a controlled manner, gradually transferring load to regrowing bone while eliminating the need for removal surgeries. The surge in demand for minimally invasive surgical techniques has steered design philosophies towards slimmer profiles and flexible dynamic stabilization devices that preserve segmental motion. Regulatory agencies have responded with streamlined pathways for innovative devices, encouraging collaboration between academia and industry. These collective advances are reshaping clinical protocols, compelling hospital systems and specialty clinics to update procedural guidelines and invest in surgeon training. As a result, the entire ecosystem-from R&D laboratories to operating theaters-embraces a new era of personalized, biologically integrated spinal care.Cumulative Impact of United States Tariff Adjustments in 2025
In 2025, heightened tariff measures imposed by the United States government have introduced new cost dynamics across the spinal implant supply chain. Duties on imported bioceramics such as alumina and carbonate apatite, as well as natural polymers including alginate and chitosan, have increased input costs for device manufacturers. Synthetic polymers like PAEK derivatives PEEK and PEKK, as well as polyglycolic acid and polylactic acid, are now subject to additional levies that influence the pricing strategy for both standard and customizable implants. The elevated tariffs have prompted several companies to reevaluate sourcing models and explore domestic production of key feedstocks. Some manufacturers are accelerating investments in local additive manufacturing hubs to bypass import restrictions on 3D-printing powders and nano-coating precursors. Hospitals and specialty clinics face marginally higher procurement costs, which may influence device selection and reimbursement negotiations. Meanwhile, raw-material substitute development is gaining momentum as R&D teams seek alternative formulations that retain biomechanical performance without triggering elevated duty classifications. Overall, the 2025 tariff landscape is compelling stakeholders to optimize operations, diversify supply sources and strengthen cost-management practices.Key Multidimensional Segmentation Insights for Market Clarity
The spinal implant market is dissected through multiple complementary lenses to capture its complexity and high degree of customization. When viewed by material composition, bioceramics emerge as a key category with alumina and carbonate apatite offering high compressive strength and osteoconductivity, while natural biomaterials such as alginate, chitosan and collagen deliver exceptional biocompatibility and cell-friendly matrices. Synthetic polymers span from PAEK family members-PEEK and PEKK-to polyglycolic acid and polylactic acid, each selected for properties ranging from rigidity to controlled degradation rates. Examining implant types reveals a clear bifurcation between fusion devices, including cages, pedicle screws, rods and plates, and motion-preserving non-fusion solutions such as artificial discs and dynamic stabilization systems. End-user segmentation highlights the dual influence of large hospital networks, which drive high-volume procurement and standardized protocols, alongside specialty clinics that foster rapid adoption of innovative, minimally invasive procedures. In terms of clinical application, implants designed for degenerative disc disease, scoliosis correction, spinal tumor management and trauma fixation each demand distinct mechanical profiles and integration pathways. Technological progress is best seen in 3D-printed implants, bioabsorbable materials with controlled or rapid degradation characteristics and advanced nano-coatings that tailor surface bioactivity. Patient demographics further refine the market, distinguishing adult, geriatric and pediatric cohorts, while surgical approach-minimally invasive versus open surgery-dictates implant geometry and instrumentation. Lastly, implant design options range from off-the-shelf standards to fully customizable geometries, mechanism of action falls between dynamic and static stabilization, and manufacturing methods extend across additive and subtractive processes. This multidimensional segmentation framework provides an integrated view of how material, design, clinical and technological variables interact to shape product strategies and procurement decisions.Key Regional Insights and Adoption Trends Across Global Markets
Regional dynamics in spinal implant adoption exhibit notable variation driven by healthcare infrastructure, reimbursement frameworks and surgical training. In the Americas, robust funding for R&D and a mature regulatory environment have fostered early market entry for 3D-printed and bioactive implants, with leading hospitals collaborating on clinical trials and real-world evidence studies. This region also shows significant uptake of motion-preserving devices, supported by insurance coverage for advanced technologies. Moving to Europe, the Middle East & Africa, cost containment pressures and diverse healthcare models have resulted in selective adoption of premium implants; however, public-private partnerships and regional manufacturing hubs are accelerating access to bioabsorbable and nano-coated options. Surgeons in this combined territory emphasize evidence of long-term outcomes and implant longevity. In the Asia-Pacific, rising healthcare expenditure, expanding specialty clinics and government incentives for local production create fertile ground for rapid proliferation of both fusion and non-fusion systems. Domestic manufacturers are increasingly competing on price and customization, while international players establish joint ventures to meet local regulatory requirements. Overall, geographic factors influence both the pace of innovation uptake and the strategic priorities of device developers.Key Competitive Insights on Leading Spinal Implant Manufacturers
Several leading manufacturers shape the competitive landscape through differentiated portfolios and strategic initiatives. Boston Scientific Corporation continues to leverage its expertise in minimally invasive therapies to expand into spinal stabilization, focusing on dynamic devices that preserve segmental motion. Depuy Synthes Companies, part of a major medical device conglomerate, drive scale advantages in fusion implants with comprehensive rods, plates and pedicle screw systems integrated with navigation technologies. Globus Medical, Inc. distinguishes itself through a robust additive manufacturing pipeline, offering anatomically optimized cage designs. Medtronic Plc maintains market leadership via a broad suite of fusion and non-fusion devices, coupled with digital surgery platforms that streamline preoperative planning. NuVasive, Inc. prioritizes lateral and axial corridor implants, enhancing access for minimally invasive procedures. Orthofix International N.V. emphasizes bioabsorbable and controlled-degradation materials to reduce reoperation rates. RTI Surgical, Inc. capitalizes on allograft and hybrid constructs for oncology and trauma indications. Seaspine Holdings Corporation focuses on integrated spinal solutions backed by vertically aligned manufacturing. Stryker Corporation exploits its orthobiologics capabilities to introduce novel nano-coatings, and Zimmer Biomet Holdings, Inc. integrates robotic guidance with its proprietary interbody devices. Together, these companies invest heavily in clinical evidence, surgeon education and strategic partnerships to maintain competitive advantage.Actionable Strategic Recommendations for Industry Leaders
To capitalize on emerging opportunities and mitigate risks, industry leaders should align on several priorities. First, invest in flexible manufacturing platforms that can switch between additive and subtractive processes, reducing lead times and bypassing tariff constraints. Second, develop modular implant systems that accommodate both fusion and dynamic stabilization approaches, meeting diverse surgical preferences and accelerating adoption. Third, strengthen partnerships with orthopedic and neurosurgical societies to conduct multicenter clinical trials that validate the efficacy of bioabsorbable materials and nano-coatings, thereby influencing reimbursement decisions. Fourth, establish regional R&D hubs in high-growth Asia-Pacific markets to tailor designs to local anatomical and regulatory requirements, while also optimizing cost structures. Fifth, pursue vertical integration for critical feedstocks such as PAEK polymers and bioceramic powders, ensuring supply chain resilience amidst shifting tariff landscapes. Finally, enhance digital ecosystems by integrating implant design software with intraoperative navigation and postoperative monitoring tools, delivering value-based care and reinforcing long-term implant performance.Conclusion on Navigating the Future of Biomaterial-Driven Spinal Devices
The confluence of material innovation, regulatory evolution and shifting clinical practices has propelled spinal implants into a new era of personalized medicine. As biomaterials mature from passive scaffolds to bioactive, resorbable and patient-specific constructs, manufacturers must embrace a holistic approach that spans R&D, manufacturing and clinical collaboration. Segmentation analysis underscores the importance of targeting solutions to distinct material types, surgical methods and patient segments, while regional insights reveal the necessity of adaptive strategies that address local adoption drivers. Competitive profiling highlights how leading companies leverage integrated portfolios and digital platforms to secure market share. By following the articulated strategic recommendations-ranging from modular design and flexible production to clinical evidence generation and supply chain integration-stakeholders can navigate tariff pressures and accelerate the transition toward next-generation implants. Ultimately, success hinges on the ability to deliver implants that offer mechanical reliability, biological compatibility and cost-effectiveness in equal measure.Market Segmentation & Coverage
This research report categorizes the Biomaterials in Spinal Implants Market to forecast the revenues and analyze trends in each of the following sub-segmentations:
- Bioceramics
- Alumina
- Carbonate Apatite
- Natural Biomaterials
- Alginate
- Chitosan
- Collagen
- Synthetic Polymers
- Polyaryletherketone (PAEK)
- PEEK
- PEKK
- Polyglycolic Acid (PGA)
- Polylactic Acid (PLA)
- Polyaryletherketone (PAEK)
- Fusion Implants
- Cages
- Pedicle Screws
- Rods and Plates
- Non-Fusion Implants
- Artificial Discs
- Dynamic Stabilization Devices
- Hospitals
- Specialty Clinics
- Degenerative Disc Disease
- Scoliosis
- Spinal Tumors
- Trauma and Fractures
- 3D-Printed Implants
- Bioabsorbable Materials
- Controlled Degradation
- Rapid Degradation
- Nano-Coatings
- Adults
- Geriatrics
- Pediatrics
- Minimally Invasive Surgery
- Open Surgery
- Herniated Disc
- Spinal Stenosis
- Spondylolisthesis
- Customizable Implants
- Standard Implants
- Dynamic Devices
- Static Devices
- Additive Manufacturing
- Subtractive Manufacturing
This research report categorizes the Biomaterials in Spinal Implants Market to forecast the revenues and analyze trends in each of the following sub-regions:
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
This research report categorizes the Biomaterials in Spinal Implants Market to delves into recent significant developments and analyze trends in each of the following companies:
- Boston Scientific Corporation
- Depuy Synthes Companies (a division of Johnson & Johnson)
- Globus Medical, Inc.
- Medtronic Plc
- NuVasive, Inc.
- Orthofix International N.V.
- RTI Surgical, Inc.
- Seaspine Holdings Corporation
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biomaterials in Spinal Implants Market, by Materials
8.1. Introduction
8.2. Bioceramics
8.2.1. Alumina
8.2.2. Carbonate Apatite
8.3. Natural Biomaterials
8.3.1. Alginate
8.3.2. Chitosan
8.3.3. Collagen
8.4. Synthetic Polymers
8.4.1. Polyaryletherketone (PAEK)
8.4.1.1. PEEK
8.4.1.2. PEKK
8.4.2. Polyglycolic Acid (PGA)
8.4.3. Polylactic Acid (PLA)
9. Biomaterials in Spinal Implants Market, by Types of Spinal Implants
9.1. Introduction
9.2. Fusion Implants
9.2.1. Cages
9.2.2. Pedicle Screws
9.2.3. Rods and Plates
9.3. Non-Fusion Implants
9.3.1. Artificial Discs
9.3.2. Dynamic Stabilization Devices
10. Biomaterials in Spinal Implants Market, by End-User
10.1. Introduction
10.2. Hospitals
10.3. Specialty Clinics
11. Biomaterials in Spinal Implants Market, by Application
11.1. Introduction
11.2. Degenerative Disc Disease
11.3. Scoliosis
11.4. Spinal Tumors
11.5. Trauma and Fractures
12. Biomaterials in Spinal Implants Market, by Technological Advancements
12.1. Introduction
12.2. 3D-Printed Implants
12.3. Bioabsorbable Materials
12.3.1. Controlled Degradation
12.3.2. Rapid Degradation
12.4. Nano-Coatings
13. Biomaterials in Spinal Implants Market, by Age Group
13.1. Introduction
13.2. Adults
13.3. Geriatrics
13.4. Pediatrics
14. Biomaterials in Spinal Implants Market, by Type of Surgery
14.1. Introduction
14.2. Minimally Invasive Surgery
14.3. Open Surgery
15. Biomaterials in Spinal Implants Market, by Spinal Conditions
15.1. Introduction
15.2. Herniated Disc
15.3. Spinal Stenosis
15.4. Spondylolisthesis
16. Biomaterials in Spinal Implants Market, by Implant Design
16.1. Introduction
16.2. Customizable Implants
16.3. Standard Implants
17. Biomaterials in Spinal Implants Market, by Mechanisms of Action
17.1. Introduction
17.2. Dynamic Devices
17.3. Static Devices
18. Biomaterials in Spinal Implants Market, by Manufacturing Process
18.1. Introduction
18.2. Additive Manufacturing
18.3. Subtractive Manufacturing
19. Americas Biomaterials in Spinal Implants Market
19.1. Introduction
19.2. Argentina
19.3. Brazil
19.4. Canada
19.5. Mexico
19.6. United States
20. Asia-Pacific Biomaterials in Spinal Implants Market
20.1. Introduction
20.2. Australia
20.3. China
20.4. India
20.5. Indonesia
20.6. Japan
20.7. Malaysia
20.8. Philippines
20.9. Singapore
20.10. South Korea
20.11. Taiwan
20.12. Thailand
20.13. Vietnam
21. Europe, Middle East & Africa Biomaterials in Spinal Implants Market
21.1. Introduction
21.2. Denmark
21.3. Egypt
21.4. Finland
21.5. France
21.6. Germany
21.7. Israel
21.8. Italy
21.9. Netherlands
21.10. Nigeria
21.11. Norway
21.12. Poland
21.13. Qatar
21.14. Russia
21.15. Saudi Arabia
21.16. South Africa
21.17. Spain
21.18. Sweden
21.19. Switzerland
21.20. Turkey
21.21. United Arab Emirates
21.22. United Kingdom
22. Competitive Landscape
22.1. Market Share Analysis, 2024
22.2. FPNV Positioning Matrix, 2024
22.3. Competitive Analysis
22.3.1. Boston Scientific Corporation
22.3.2. Depuy Synthes Companies (a division of Johnson & Johnson)
22.3.3. Globus Medical, Inc.
22.3.4. Medtronic Plc
22.3.5. NuVasive, Inc.
22.3.6. Orthofix International N.V.
22.3.7. RTI Surgical, Inc.
22.3.8. Seaspine Holdings Corporation
22.3.9. Stryker Corporation
22.3.10. Zimmer Biomet Holdings, Inc.
23. ResearchAI
24. ResearchStatistics
25. ResearchContacts
26. ResearchArticles
27. Appendix
List of Figures
FIGURE 1. BIOMATERIALS IN SPINAL IMPLANTS MARKET MULTI-CURRENCY
FIGURE 2. BIOMATERIALS IN SPINAL IMPLANTS MARKET MULTI-LANGUAGE
FIGURE 3. BIOMATERIALS IN SPINAL IMPLANTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIALS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIALS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPES OF SPINAL IMPLANTS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPES OF SPINAL IMPLANTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPE OF SURGERY, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPE OF SURGERY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL CONDITIONS, 2024 VS 2030 (%)
FIGURE 22. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL CONDITIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY IMPLANT DESIGN, 2024 VS 2030 (%)
FIGURE 24. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY IMPLANT DESIGN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MECHANISMS OF ACTION, 2024 VS 2030 (%)
FIGURE 26. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MECHANISMS OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2030 (%)
FIGURE 28. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MANUFACTURING PROCESS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 32. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 36. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 37. BIOMATERIALS IN SPINAL IMPLANTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 38. BIOMATERIALS IN SPINAL IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOMATERIALS IN SPINAL IMPLANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIALS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOCERAMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY ALUMINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY CARBONATE APATITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOCERAMICS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NATURAL BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY ALGINATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY CHITOSAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYARYLETHERKETONE (PAEK), BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEEK, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEKK, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYARYLETHERKETONE (PAEK), 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYLACTIC ACID (PLA), BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPES OF SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY FUSION IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY CAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDICLE SCREWS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RODS AND PLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NON-FUSION IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY ARTIFICIAL DISCS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DYNAMIC STABILIZATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NON-FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DEGENERATIVE DISC DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SCOLIOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TRAUMA AND FRACTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY 3D-PRINTED IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOABSORBABLE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY CONTROLLED DEGRADATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY RAPID DEGRADATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOABSORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NANO-COATINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPE OF SURGERY, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL CONDITIONS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY HERNIATED DISC, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL STENOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPONDYLOLISTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY IMPLANT DESIGN, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY CUSTOMIZABLE IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY STANDARD IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MECHANISMS OF ACTION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY DYNAMIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY STATIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY ADDITIVE MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SUBTRACTIVE MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIALS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOCERAMICS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYARYLETHERKETONE (PAEK), 2018-2030 (USD MILLION)
TABLE 74. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPES OF SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NON-FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOABSORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPE OF SURGERY, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL CONDITIONS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY IMPLANT DESIGN, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MECHANISMS OF ACTION, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIALS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOCERAMICS, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYARYLETHERKETONE (PAEK), 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPES OF SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NON-FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOABSORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPE OF SURGERY, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL CONDITIONS, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY IMPLANT DESIGN, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MECHANISMS OF ACTION, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIALS, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOCERAMICS, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYARYLETHERKETONE (PAEK), 2018-2030 (USD MILLION)
TABLE 111. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPES OF SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NON-FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOABSORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPE OF SURGERY, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL CONDITIONS, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY IMPLANT DESIGN, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MECHANISMS OF ACTION, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 124. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIALS, 2018-2030 (USD MILLION)
TABLE 125. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOCERAMICS, 2018-2030 (USD MILLION)
TABLE 126. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 127. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 128. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYARYLETHERKETONE (PAEK), 2018-2030 (USD MILLION)
TABLE 129. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPES OF SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 130. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 131. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NON-FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 132. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 135. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOABSORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 136. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 137. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPE OF SURGERY, 2018-2030 (USD MILLION)
TABLE 138. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL CONDITIONS, 2018-2030 (USD MILLION)
TABLE 139. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY IMPLANT DESIGN, 2018-2030 (USD MILLION)
TABLE 140. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MECHANISMS OF ACTION, 2018-2030 (USD MILLION)
TABLE 141. CANADA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 142. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIALS, 2018-2030 (USD MILLION)
TABLE 143. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOCERAMICS, 2018-2030 (USD MILLION)
TABLE 144. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 145. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 146. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYARYLETHERKETONE (PAEK), 2018-2030 (USD MILLION)
TABLE 147. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPES OF SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 148. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 149. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NON-FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 150. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 153. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOABSORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 154. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 155. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPE OF SURGERY, 2018-2030 (USD MILLION)
TABLE 156. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL CONDITIONS, 2018-2030 (USD MILLION)
TABLE 157. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY IMPLANT DESIGN, 2018-2030 (USD MILLION)
TABLE 158. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MECHANISMS OF ACTION, 2018-2030 (USD MILLION)
TABLE 159. MEXICO BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIALS, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOCERAMICS, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYARYLETHERKETONE (PAEK), 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPES OF SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NON-FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOABSORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPE OF SURGERY, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL CONDITIONS, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY IMPLANT DESIGN, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MECHANISMS OF ACTION, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIALS, 2018-2030 (USD MILLION)
TABLE 180. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOCERAMICS, 2018-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 182. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYARYLETHERKETONE (PAEK), 2018-2030 (USD MILLION)
TABLE 184. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPES OF SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 186. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NON-FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 190. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOABSORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPE OF SURGERY, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL CONDITIONS, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY IMPLANT DESIGN, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MECHANISMS OF ACTION, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 198. AUSTRALIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIALS, 2018-2030 (USD MILLION)
TABLE 199. AUSTRALIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOCERAMICS, 2018-2030 (USD MILLION)
TABLE 200. AUSTRALIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 201. AUSTRALIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 202. AUSTRALIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYARYLETHERKETONE (PAEK), 2018-2030 (USD MILLION)
TABLE 203. AUSTRALIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPES OF SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 204. AUSTRALIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 205. AUSTRALIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NON-FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 206. AUSTRALIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. AUSTRALIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. AUSTRALIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 209. AUSTRALIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOABSORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 210. AUSTRALIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 211. AUSTRALIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPE OF SURGERY, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL CONDITIONS, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY IMPLANT DESIGN, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MECHANISMS OF ACTION, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 216. CHINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIALS, 2018-2030 (USD MILLION)
TABLE 217. CHINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOCERAMICS, 2018-2030 (USD MILLION)
TABLE 218. CHINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 219. CHINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 220. CHINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYARYLETHERKETONE (PAEK), 2018-2030 (USD MILLION)
TABLE 221. CHINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPES OF SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 222. CHINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 223. CHINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NON-FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 224. CHINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. CHINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. CHINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 227. CHINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOABSORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 228. CHINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 229. CHINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPE OF SURGERY, 2018-2030 (USD MILLION)
TABLE 230. CHINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL CONDITIONS, 2018-2030 (USD MILLION)
TABLE 231. CHINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY IMPLANT DESIGN, 2018-2030 (USD MILLION)
TABLE 232. CHINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MECHANISMS OF ACTION, 2018-2030 (USD MILLION)
TABLE 233. CHINA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 234. INDIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIALS, 2018-2030 (USD MILLION)
TABLE 235. INDIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOCERAMICS, 2018-2030 (USD MILLION)
TABLE 236. INDIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 237. INDIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 238. INDIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYARYLETHERKETONE (PAEK), 2018-2030 (USD MILLION)
TABLE 239. INDIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPES OF SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 240. INDIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 241. INDIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NON-FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 242. INDIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 243. INDIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. INDIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 245. INDIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOABSORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 246. INDIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 247. INDIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPE OF SURGERY, 2018-2030 (USD MILLION)
TABLE 248. INDIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL CONDITIONS, 2018-2030 (USD MILLION)
TABLE 249. INDIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY IMPLANT DESIGN, 2018-2030 (USD MILLION)
TABLE 250. INDIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MECHANISMS OF ACTION, 2018-2030 (USD MILLION)
TABLE 251. INDIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 252. INDONESIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIALS, 2018-2030 (USD MILLION)
TABLE 253. INDONESIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOCERAMICS, 2018-2030 (USD MILLION)
TABLE 254. INDONESIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 255. INDONESIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 256. INDONESIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYARYLETHERKETONE (PAEK), 2018-2030 (USD MILLION)
TABLE 257. INDONESIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPES OF SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 258. INDONESIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 259. INDONESIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NON-FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 260. INDONESIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. INDONESIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. INDONESIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 263. INDONESIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOABSORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 264. INDONESIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 265. INDONESIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPE OF SURGERY, 2018-2030 (USD MILLION)
TABLE 266. INDONESIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL CONDITIONS, 2018-2030 (USD MILLION)
TABLE 267. INDONESIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY IMPLANT DESIGN, 2018-2030 (USD MILLION)
TABLE 268. INDONESIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MECHANISMS OF ACTION, 2018-2030 (USD MILLION)
TABLE 269. INDONESIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 270. JAPAN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIALS, 2018-2030 (USD MILLION)
TABLE 271. JAPAN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOCERAMICS, 2018-2030 (USD MILLION)
TABLE 272. JAPAN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 273. JAPAN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 274. JAPAN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYARYLETHERKETONE (PAEK), 2018-2030 (USD MILLION)
TABLE 275. JAPAN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPES OF SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 276. JAPAN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 277. JAPAN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NON-FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 278. JAPAN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 279. JAPAN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. JAPAN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 281. JAPAN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOABSORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 282. JAPAN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 283. JAPAN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPE OF SURGERY, 2018-2030 (USD MILLION)
TABLE 284. JAPAN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SPINAL CONDITIONS, 2018-2030 (USD MILLION)
TABLE 285. JAPAN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY IMPLANT DESIGN, 2018-2030 (USD MILLION)
TABLE 286. JAPAN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MECHANISMS OF ACTION, 2018-2030 (USD MILLION)
TABLE 287. JAPAN BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 288. MALAYSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY MATERIALS, 2018-2030 (USD MILLION)
TABLE 289. MALAYSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY BIOCERAMICS, 2018-2030 (USD MILLION)
TABLE 290. MALAYSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 291. MALAYSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 292. MALAYSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY POLYARYLETHERKETONE (PAEK), 2018-2030 (USD MILLION)
TABLE 293. MALAYSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY TYPES OF SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 294. MALAYSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 295. MALAYSIA BIOMATERIALS IN SPINAL IMPLANTS MARKET SIZE, BY NON-FUSION IMPLANTS, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA BIOMATERIALS IN
Companies Mentioned
- Boston Scientific Corporation
- Depuy Synthes Companies (a division of Johnson & Johnson)
- Globus Medical, Inc.
- Medtronic Plc
- NuVasive, Inc.
- Orthofix International N.V.
- RTI Surgical, Inc.
- Seaspine Holdings Corporation
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
Methodology
LOADING...
